Cargando…
Current therapies and mortality in acromegaly
Acromegaly is a rare disease most frequently due to a GH secreting pituitary adenoma. Without an appropriate therapy, life of patients with acromegaly can be shortened with ten years. Pituitary surgery is usually the first line therapy for GH secreting pituitary adenomas. A meta-analysis proved that...
Autores principales: | Găloiu, S, Poiană, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656943/ https://www.ncbi.nlm.nih.gov/pubmed/26664461 |
Ejemplares similares
-
Clinical features and complications of acromegaly at diagnosis are not all the same: data from two large referral centers
por: Varlamov, Elena V, et al.
Publicado: (2021) -
Vertebral Fractures in Acromegaly: A Systematic Review
por: Sorohan, Madalina Cristina, et al.
Publicado: (2022) -
Disposition Index in Active Acromegaly
por: Niculescu, Dan Alexandru, et al.
Publicado: (2019) -
Determinants of morbidities and mortality in acromegaly
por: Kasuki, Leandro, et al.
Publicado: (2019) -
Novel therapies for acromegaly
por: Maia, Bernardo, et al.
Publicado: (2020)